نتایج جستجو برای: ldlr locus

تعداد نتایج: 69565  

Journal: :The Journal of clinical investigation 1998
M M Véniant C H Zlot R L Walzem V Pierotti R Driscoll D Dichek J Herz S G Young

The role of the low density lipoprotein receptor (LDLR) in the clearance of apo-B48-containing lipoproteins and the role of the LDLR-related protein (LRP) in the removal of apo-B100-containing lipoproteins have not been clearly defined. To address these issues, we characterized LDLR-deficient mice homozygous for an "apo-B48-only" allele, an "apo-B100-only" allele, or a wild-type apo-B allele (L...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2005
Kara N Maxwell Edward A Fisher Jan L Breslow

Proprotein convertase subtilisin kexin 9 (PCSK9) is a member of the subtilisin serine protease family with an important role in cholesterol metabolism. PCSK9 expression is regulated by dietary cholesterol in mice and cellular sterol levels in cell culture via the sterol regulatory element binding protein transcription factors, and mutations in PCSK9 are associated with a form of autosomal domin...

Journal: :The Journal of nutrition 2009
Viswanathan Saraswathi Jason D Morrow Alyssa H Hasty

Obesity is often associated with dyslipidemia, insulin resistance, and hypertension. Together, these metabolic perturbations greatly increase the risk of developing cardiovascular disease and diabetes. Although fish oil is a well-established hypolipidemic agent, the mechanisms by which it mediates its lipid-lowering effects are not clear. In addition, it has not been established whether dietary...

2013
Maryssa Canuel Xiaowei Sun Marie-Claude Asselin Eustache Paramithiotis Annik Prat Nabil G. Seidah

Elevated LDL-cholesterol (LDLc) levels are a major risk factor for cardiovascular disease and atherosclerosis. LDLc is cleared from circulation by the LDL receptor (LDLR). Proprotein convertase subtilisin/kexin 9 (PCSK9) enhances the degradation of the LDLR in endosomes/lysosomes, resulting in increased circulating LDLc. PCSK9 can also mediate the degradation of LDLR lacking its cytosolic tail,...

Journal: :Circulation 2006
Christos E Chadjichristos Christian M Matter Isabelle Roth Esther Sutter Graziano Pelli Thomas F Lüscher Marc Chanson Brenda R Kwak

BACKGROUND Reducing the expression of the gap junction protein connexin43 (Cx43) inhibits the progression of atherosclerosis, a chronic inflammatory disease. Furthermore, acute vascular injury induced by percutaneous coronary interventions is associated with increased Cx43 expression in neointimal smooth muscle cells (SMCs). However, the relevance of Cx43 after acute vascular injury remains unc...

2017
Koji Akita Kikuo Isoda Yayoi Sato-Okabayashi Tomoyasu Kadoguchi Kenichi Kitamura Fumie Ohtomo Kazunori Shimada Hiroyuki Daida

IκBNS is a nuclear IκB protein which negatively regulates nuclear factor-κB activity. We demonstrated that IκBNS deficiency accelerates atherosclerosis in LDL receptor-deficient (LDLr-/-) mice via increased interleukin (IL)-6 production by macrophages. Previous studies showed that the increase in IL-6 might contribute to the development of atherosclerotic lesions. However, whether an anti-mouse...

Journal: :The Journal of biological chemistry 2008
Daniel A Blasiole Angie T Oler Alan D Attie

Apolipoprotein B (apoB) is required for the hepatic assembly and secretion of very low density lipoprotein (VLDL). The LDL receptor (LDLR) promotes post-translational degradation of apoB and thereby reduces VLDL particle secretion. We investigated the trafficking pathways and ligand requirements for the LDLR to promote degradation of apoB. We first tested whether the LDLR drives apoB degradatio...

Journal: :International journal of advanced research 2022

Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder with a very high prevalence of almost 1 in 200-500 people. Genetic testings have commonly revealed mutations genes namely LDLR, APOB, and PCSK9. In order to provide better management minimize the risk premature Coronary heart disease (CHD) affected people, early identification FH patients screening their first-degree r...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2009
Joyce C Y Chan Derek E Piper Qiong Cao Dongming Liu Chadwick King Wei Wang Jie Tang Qiang Liu Jared Higbee Zhen Xia Yongmei Di Susan Shetterly Ziva Arimura Heather Salomonis William G Romanow Stephen T Thibault Richard Zhang Ping Cao Xiao-Ping Yang Timothy Yu Mei Lu Marc W Retter Gayle Kwon Kirk Henne Oscar Pan Mei-Mei Tsai Bryna Fuchslocher Evelyn Yang Lei Zhou Ki Jeong Lee Mark Daris Jackie Sheng Yan Wang Wenyan D Shen Wen-Chen Yeh Maurice Emery Nigel P C Walker Bei Shan Margrit Schwarz Simon M Jackson

Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates serum LDL cholesterol (LDL-C) by interacting with the LDL receptor (LDLR) and is an attractive therapeutic target for LDL-C lowering. We have generated a neutralizing anti-PCSK9 antibody, mAb1, that binds to an epitope on PCSK9 adjacent to the region required for LDLR interaction. In vitro, mAb1 inhibits PCSK9 binding to the LDLR a...

Journal: :Hypertension 2014
Chiung-Kuei Huang Haiyan Pang Lin Wang Yuanjie Niu Jie Luo Eugene Chang Janet D Sparks Soo Ok Lee Chawnshang Chang

The male sex has a higher risk to develop coronary artery diseases, including atherosclerosis. The androgen receptor (AR) is expressed in several atherosclerosis-associated cell types, including monocytes/macrophages, endothelial cells (ECs), and smooth muscle cells (SMCs), but its pathophysiological role in each cell type during the development of atherosclerotic lesions remains unclear. Using...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید